IL138339A0 - Mutant recombinant allergens - Google Patents

Mutant recombinant allergens

Info

Publication number
IL138339A0
IL138339A0 IL13833999A IL13833999A IL138339A0 IL 138339 A0 IL138339 A0 IL 138339A0 IL 13833999 A IL13833999 A IL 13833999A IL 13833999 A IL13833999 A IL 13833999A IL 138339 A0 IL138339 A0 IL 138339A0
Authority
IL
Israel
Prior art keywords
allergens
recombinant allergens
mutant recombinant
disclosed
recombinant
Prior art date
Application number
IL13833999A
Other languages
English (en)
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL138339(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of IL138339A0 publication Critical patent/IL138339A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13833999A 1998-03-16 1999-03-16 Mutant recombinant allergens IL138339A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK36498 1998-03-16
PCT/DK1999/000136 WO1999047680A1 (en) 1998-03-16 1999-03-16 Mutant recombinant allergens

Publications (1)

Publication Number Publication Date
IL138339A0 true IL138339A0 (en) 2001-10-31

Family

ID=8092687

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13833999A IL138339A0 (en) 1998-03-16 1999-03-16 Mutant recombinant allergens
IL138339A IL138339A (en) 1998-03-16 2000-09-07 Non naturally occurring mutant recombinant allergens, methods for their preparation and pharmaceutical compositions comprising them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL138339A IL138339A (en) 1998-03-16 2000-09-07 Non naturally occurring mutant recombinant allergens, methods for their preparation and pharmaceutical compositions comprising them

Country Status (19)

Country Link
US (1) US20040091500A1 (enExample)
EP (1) EP1062341B1 (enExample)
JP (1) JP2002506648A (enExample)
KR (1) KR20010041918A (enExample)
CN (1) CN1332029C (enExample)
AT (1) ATE408690T1 (enExample)
AU (1) AU749749B2 (enExample)
CA (1) CA2323687C (enExample)
DE (1) DE69939584D1 (enExample)
DK (1) DK1062341T3 (enExample)
ES (1) ES2313776T3 (enExample)
HU (1) HUP0101464A3 (enExample)
IL (2) IL138339A0 (enExample)
NO (1) NO328354B1 (enExample)
NZ (1) NZ506665A (enExample)
PL (1) PL194804B1 (enExample)
PT (1) PT1062341E (enExample)
WO (1) WO1999047680A1 (enExample)
ZA (1) ZA200004819B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226770B2 (en) * 2000-04-28 2007-06-05 Novozymes A/S Lipolytic enzyme variant
IT1318690B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti dell'allergene maggiore par j 2 di parietaria judaica.
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
ATE403152T1 (de) * 2000-10-17 2008-08-15 Besst Test Aps Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe
PL214225B1 (pl) * 2000-11-16 2013-07-31 Alk Abello As Zrekombinowany alergen, zastosowanie zrekombinowanego alergenu, kompozycja farmaceutyczna, sposób przygotowania kompozycji farmaceutycznej, sposób przygotowania zrekombinowanego alergenu, sekwencja DNA kodujaca zrekombinowany alergen, wektor ekspresyjny, komórka gospodarza oraz sposób produkcji zrekombinowanego zmutowanego alergenu
DK1219300T3 (da) * 2000-12-28 2007-03-05 Biomay Prod & Handel Behandling af allergi
EP1499349B1 (en) * 2001-03-02 2009-11-18 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
WO2003031981A2 (en) * 2001-10-05 2003-04-17 Novozymes A/S Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
PT1478662E (pt) * 2002-02-27 2009-12-29 Merck Patent Gmbh Método para o fabrico do alergeno principal do pólen de bétula hipoalergénico rbet v 1
EP1504089A2 (en) * 2002-05-16 2005-02-09 Alk Abell A/S Allergen mutants
JP2006520184A (ja) * 2002-11-01 2006-09-07 アルカベロ アクチェセルスカプ 組換えタンパク質変種
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
CA2516291C (en) 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
EP2272502A1 (en) 2003-12-19 2011-01-12 Alk-Abelló A/S Cryogranules of a liquid composition of an allergen product
EP2324850A1 (en) 2005-10-04 2011-05-25 Alk-Abelló A/S Solid vaccine formulation
ITMI20052517A1 (it) * 2005-12-29 2007-06-30 Lofarma Spa Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa
JP2009534029A (ja) * 2006-04-20 2009-09-24 ナショナル ユニバーシティ オブ シンガポール 組換え乳酸桿菌およびその使用
CN101657213B (zh) * 2007-02-15 2014-02-26 曼康公司 用于增强t细胞应答的方法
EP1974746B1 (en) 2007-03-28 2012-01-11 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
EP2028188A1 (en) * 2007-08-21 2009-02-25 Biomay AG Hypoallergenic molecules
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
WO2010146171A1 (en) 2009-06-19 2010-12-23 Alk-Abelló A/S Novel manner of administering allergen in allergen specific immunotherapy
CN102584966A (zh) * 2011-11-14 2012-07-18 广州医学院第二附属医院 一种重组花生过敏原与突变体及其制备方法和应用
CN102690340A (zh) * 2012-03-30 2012-09-26 广州医学院第二附属医院 一种重组巴西坚果过敏原与突变体及其制备方法和应用
CN102617719A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组大米过敏原与突变体及其制备方法和应用
CN102603879A (zh) * 2012-03-30 2012-07-25 广州医学院第二附属医院 一种重组大豆过敏原与突变体及其制备方法和应用
CN102617715A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组真菌主要过敏原与突变体及其制备方法和应用
CN102675439A (zh) * 2012-03-31 2012-09-19 广州医学院第二附属医院 一种重组黑麦草花粉过敏原与突变体的制备方法和应用
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
EP4058059B1 (en) * 2019-11-13 2024-10-09 The Regents Of The University Of Michigan Nanoemulsion compositions for treating aeroallergen associated allergy and inflammation
CN111187606B (zh) * 2020-02-25 2022-06-14 江苏海洋大学 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
CA2319437C (en) * 1998-01-31 2009-06-16 University Of Arkansas Methods and reagents for decreasing allergic reactions
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.

Also Published As

Publication number Publication date
ES2313776T3 (es) 2009-03-01
CA2323687C (en) 2008-11-25
NO20004614D0 (no) 2000-09-15
ZA200004819B (en) 2001-05-30
HUP0101464A3 (en) 2004-10-28
NO20004614L (no) 2000-10-26
WO1999047680A1 (en) 1999-09-23
AU749749B2 (en) 2002-07-04
US20040091500A1 (en) 2004-05-13
CN1332029C (zh) 2007-08-15
AU2714799A (en) 1999-10-11
DK1062341T3 (da) 2008-11-03
EP1062341B1 (en) 2008-09-17
PT1062341E (pt) 2008-12-24
NO328354B1 (no) 2010-02-01
JP2002506648A (ja) 2002-03-05
PL343029A1 (en) 2001-07-30
KR20010041918A (ko) 2001-05-25
HK1033591A1 (en) 2001-09-07
HUP0101464A2 (hu) 2001-08-28
CN1293710A (zh) 2001-05-02
IL138339A (en) 2009-06-15
ATE408690T1 (de) 2008-10-15
DE69939584D1 (de) 2008-10-30
CA2323687A1 (en) 1999-09-23
EP1062341A1 (en) 2000-12-27
NZ506665A (en) 2003-08-29
PL194804B1 (pl) 2007-07-31

Similar Documents

Publication Publication Date Title
ZA200004819B (en) Mutant recombinant allergens.
AU2350502A (en) Novel mutant allergens
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
WO2003020889A3 (en) Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
IL145795A0 (en) Mutant human cd80 and compositions for and methods of making and using the same
WO2003000113A3 (en) Compositions and methods for the diagnosis and treatment of tumor
AP2001002187A0 (en) Piperidines as CCR5 modulators.
AU3227700A (en) Skin sanitizing compositions
BG102818A (en) D-manitol and method for its preparation
MX9801159A (es) Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob.
AU5605398A (en) Novel methods and compositions for treatment of autoimmune diseases
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
HU9602740D0 (en) Halofanthine free base for the treatment of malaria and compositions
ATE284708T1 (de) T-zellimpfung zur behandlung von multiple sclerosis
EP1946767A3 (en) Autologous T-cell vaccines against multiple sclerosis
BG101787A (en) Aprotinine options having improved properties
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
WO2001083722A3 (en) Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
IL153576A0 (en) Dna vaccines encoding hiv accessory proteins
GB2374871A (en) Peptide fragments of colostrinin and their use
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
AU7079300A (en) Compositions and methods for the treatment of immune related diseases